INTERPOL Operation Pangea XVIII Seizes 6.42 Million Counterfeit and Unapproved Pharmaceutical Doses
Counterfeit medicine is not just fraud with a pharmacy label. It is a public-health attack surface - and INTERPOL’s latest global operation shows how aggressively criminals are exploiting online demand for fast, cheap, and unverified treatments.
Operation Pangea XVIII, coordinated by INTERPOL from 10 to 23 March 2026, resulted in the seizure of 6.42 million doses of unapproved and counterfeit pharmaceuticals worth USD 15.5 million across 90 countries and territories.
What Happened
INTERPOL said the global crackdown led to 269 arrests and the dismantling of 66 criminal groups involved in the illicit pharmaceutical trade.
Law enforcement agencies launched 392 investigations and executed 158 search warrants targeting networks distributing unapproved, counterfeit, substandard, and falsified medical products.
The operation also hit the digital infrastructure behind the trade. Authorities disrupted approximately 5,700 criminal-linked websites, social media pages, channels, and automated bots used to market and sell illicit medicines.
What Was Seized
The most commonly seized products included erectile dysfunction medications, sedatives, analgesics, antibiotics, and anti-smoking products.
INTERPOL’s annex listed erectile dysfunction medications as the largest seized category, with 682,317 doses recovered. Hypnotics and sedatives followed with 620,949 doses, analgesics with 502,611 doses, anti-bacterials and antibiotics with 465,473 doses, and anti-smoking products with 376,143 doses.
The operation also recovered 149,092 doses of anti-parasitic medicines, 95,776 anti-inflammatory or anti-rheumatic medications, 87,838 psychotherapeutic agents, and 86,732 anabolic steroid doses.
Why This Stands Out
The seizure numbers are large, but the more important signal is the product mix. INTERPOL said misinformation and online channels are helping fuel demand for unapproved antiparasitics, steroids, lifestyle medications, peptides, and weight-loss-related products.
Anti-parasitic medicines saw a sharp rise in seizures, a trend INTERPOL linked to online promotion of substances such as ivermectin and fenbendazole as alternative cancer treatments. Fenbendazole is a veterinary deworming agent, while ivermectin is used for certain parasite and worm infections.
These products are often mislabelled as health supplements or bundled into so-called “cancer treatment kits,” making them easier to sell online while avoiding normal medical oversight.
Lifestyle Drugs Are Becoming a Criminal Growth Market
Operation Pangea XVIII also exposed demand for performance and lifestyle pharmaceuticals. INTERPOL said anabolic steroids remained a dominant illicit category, with 86,732 doses seized globally.
Authorities in Bulgaria dismantled a clandestine anabolic steroid production facility and seized millions of mislabelled pills, ampoules, and injectables.
Peptides were another concern. These synthetic substances are promoted online for muscle growth, fat loss, and recovery, often under labels such as “research chemicals” or “cosmetic peptides” to avoid scrutiny despite lacking approved dosage or safety standards for human use.
High demand for GLP-1 medicines, originally developed for diabetes and now widely associated with weight loss, has also created openings for criminal networks. INTERPOL said illicit versions are often manufactured in Asia and sold online for as little as USD 10. Some have been found to contain sibutramine, a substance banned in many countries because of links to heart attacks and strokes.
Africa Saw a Different Pattern
INTERPOL said participation from 12 African countries revealed a clearer picture of illicit medicine flows across the region. Unlike other regions, seizures in Africa mainly involved essential medicines such as painkillers, antibiotics, and antimalarials.
In Burkina Faso, authorities intercepted 384,000 antibiotic capsules. In Côte d’Ivoire, one tonne of counterfeit ibuprofen was seized from a single vehicle. In Cameroon, authorities intercepted thousands of bottles of suspected counterfeit antimalarials and antibiotics.
This matters because the risk profile is different. In regions where access to affordable healthcare is limited, criminal networks can exploit real treatment demand by pushing expired, falsified, substandard, or improperly stored medicines into informal markets.
Countries With the Highest Seizure Volumes
According to INTERPOL, the United Kingdom recorded the highest number of seized illicit pharmaceutical doses, with 2,122,591 doses recovered through combined data from the Medicines and Healthcare products Regulatory Agency, UK Border Force, and the Department of Health Northern Ireland.
Colombia followed with 1,473,434 doses, Australia with 752,617, Burkina Faso with 430,360, Türkiye with 344,874, the United States with 342,610, Canada with 269,940, Ireland with 157,422, Malaysia with 130,866, and France with 109,748.
Why Cyber Defenders Should Care
Although this is framed as a pharmaceutical crime operation, the enforcement data has a clear cybercrime dimension. The sales pipeline for illicit medicine increasingly runs through websites, social media pages, private channels, automated bots, and informal digital marketplaces.
That creates a familiar abuse pattern: criminals use online advertising, search manipulation, fake legitimacy signals, encrypted messaging, bot-driven promotion, and cross-border payments to move dangerous products at scale.
For defenders, platform trust and abuse teams, the lesson is direct. The same infrastructure used to push phishing kits, counterfeit goods, crypto scams, and malware can also be used to sell falsified medicines. Takedowns cannot stop at the website. They need to include payment rails, hosting providers, social accounts, bot networks, ad abuse, logistics nodes, and repeat seller identities.
The Bigger Picture
Operation Pangea has been running for nearly two decades, but the threat has changed. The market is no longer only rogue online pharmacies selling obvious counterfeit pills. It now includes social-media wellness narratives, influencer-style product promotion, AI-amplified misinformation, lifestyle drug demand, and direct-to-consumer sales through informal channels.
That shift makes enforcement harder. A fake pharmacy website can be blocked. A rolling ecosystem of social posts, messaging channels, bots, resellers, and short-lived storefronts is more resilient.
The health impact is also sharper. Counterfeit or unapproved products may contain the wrong ingredient, too little active ingredient, too much active ingredient, banned substances, contaminants, or no therapeutic ingredient at all. In the case of antibiotics, falsified or poor-quality products can also contribute to treatment failure and antimicrobial resistance.
NeuraCyb's Assessment
Operation Pangea XVIII shows that illicit pharmaceuticals have become a hybrid threat: part organized crime, part platform abuse, part public-health risk, and part misinformation economy.
The seizure of 6.42 million doses is significant, but the harder problem is the machinery behind them — the websites, bots, social channels, false medical claims, and cross-border supply chains that turn anxiety and demand into revenue. For defenders and enforcement teams, the target is no longer just the counterfeit pill. It is the digital system that sells trust before it sells the drug.
References
INTERPOL: Global crackdown on illicit pharmaceuticals sees USD 15.5 million in seizures
Reuters: Global crackdown on illicit pharmaceuticals sees USD 15.5 million in seizures
